Latest news with #Mother'sMilk
Yahoo
02-05-2025
- Business
- Yahoo
Is Altria Group, Inc. (MO) Among the Best Tobacco and Cigarette Stocks to Buy Now?
We recently compiled a list of the 10 Best Tobacco and Cigarette Stocks to Buy Now. In this article, we are going to take a look at where Altria Group, Inc. (NYSE:MO) stands against the other Tobacco and Cigarette stocks. Cigarette and tobacco stocks are companies that produce and sell cigars, snuff, chewing tobacco, cigarettes, e-cigarettes, and all other tobacco products. The tobacco industry has long been a huge winner for investors. Tobacco companies were among the top performers during the 20th century because of their reputation for providing investors with substantial dividend yields as well as their addictive, extremely profitable, and recession-proof product. However, tobacco firms now confront a different set of challenges. Globally, smoking rates have been progressively declining, particularly in the United States, as a result of growing legislation and health concerns. The industry has attempted to shift to next-generation products as a result. Some people believe that e-cigarettes, vaporizers, and chewable nicotine pouches are healthier options since they avoid some of the negative aspects of smoking cigarettes, such as unpleasant odors. Some companies are expanding beyond tobacco, working with cannabis businesses to capitalize on the potential development in a market that shares numerous similarities with tobacco. There are other hazards associated with tobacco stocks, such as heightened regulation and a decline in smoking rates. According to the Centers for Disease Control and Prevention, the number of tobacco farms in the United States decreased from 93,530 in 1997 to roughly 3,000 in 2022. Nonetheless, the USA was the world's fifth-largest producer of tobacco in 2021, harvesting 431.6 million pounds in 2022, compared to 1.74 billion pounds in 1997. Seventy-seven percent of U.S. production came from North Carolina or Kentucky. Price reductions accounted for $5.7 billion (72%) of the $8.6 billion tobacco businesses spent on advertising in 2022, which included $572.7 million for smokeless tobacco and $8.01 billion for cigarettes. Marketing costs for e-cigarettes came to $859.4 million in 2021. Sales of cigarette packs fell from 12.5 billion to 9.1 billion packs between 2015 and 2021, a 27% decrease. In 2024, the average cigarette tax in each state was $1.93, while the federal tax was $1.01. Despite the industry's weak revenue and profit development, investors continue to be drawn to these stocks due to their consistent dividends, profitability, and solid profit margins. Investors believe that stronger growth will eventually be catalyzed by next-generation products. However, on April 2, 2025, the U.S. Supreme Court upheld the FDA's decision to deny approval for flavored e-cigarettes in a major decision. According to Justice Samuel Alito, vape producers were given 'adequate notice' of the FDA's review criteria. In this case, businesses like Vapetasia and Triton Distribution applied for certification for products such as 'Mother's Milk and Cookies' and 'Killer Kustard Blueberry.' The FDA has been regulating vaping products since 2016, claiming that flavored vapes represent a health concern and may encourage young people to use tobacco. More than 2.1 million youths in the US reported using e-cigarettes in 2023, with 10% of high school students vaping. The FDA has rejected thousands of flavored products and has only approved tobacco and menthol flavors. One specific issue, marketing plan consideration, was returned to lower courts after the Supreme Court reversed the 5th Circuit's prior criticism of the FDA's changing criteria. Companies that promote unapproved products risk 'civil and criminal penalties,' the FDA warned. A close-up of an assembly line with a blend of tobacco products. For this article, we sifted through the online rankings to form an initial list of the 15 Tobacco and Cigarette Stocks. We have also included e-cigarette and cannabis companies. From the resultant dataset, we chose 10 stocks with the highest number of hedge fund investors, using Insider Monkey's database of 1009 hedge funds in Q4 2024 to gauge hedge fund sentiment for stocks. We have used the stock's market cap as of April 25, 2025, as a tie-breaker in case two or more stocks have the same number of hedge funds invested. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here). Number of Hedge Fund Holders: 47 Altria Group, Inc. (NYSE:MO) is one of the Best Tobacco Stocks headquartered in Virginia. It produces a variety of connected goods, such as cigarettes and other products that contain nicotine. The company's business model tends to endure well in times of market and economic turmoil, and it also specializes in nicotine products. The US is seeing a decline in traditional cigarette consumption, but overall demand for nicotine is still stable. The business has a lot of advantages because it owns about half of the US market. These include cost savings from its size, significant bargaining power with retailers since it owns popular brands like JUUL and Marlboro, and the capacity to make larger investments than rivals in more recent nicotine substitutes, including smokeless products. Altria Group, Inc. (NYSE:MO) reported $5.11 billion in revenue for the last quarter of 2024, a 1.63% year-over-year gain that was $59.6 million higher than analyst projections. Improved margins and strong performance across its main tobacco brands helped to fuel the expansion. Furthermore, the business kept investing in projects that promote long-term growth. It projects adjusted diluted EPS for 2025 to range from $5.22 to $5.37, representing a 2% to 5% growth over its 2024 earnings of $5.12 per share. Citi increased its target price for Altria Group, Inc. (NYSE:MO) from $52 to $55. Given the challenging U.S. environment and NJOY's delisting, the company anticipates a 'weak' first quarter for the firm. Citi, however, sees 'solid On!' volume growth. Overall, MO ranks 2nd on our list of the 10 Best Tobacco and Cigarette Stocks to Buy Now. While we acknowledge the potential of Tobacco and Cigarette companies, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than MO but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Telegraph
20-04-2025
- Entertainment
- Telegraph
Love the Melrose novels? Things have gone downhill
The Patrick Melrose sequence, by Edward St Aubyn, comprises five autobiographical novels, including the Booker-shortlisted Mother's Milk (2005). They document Melrose's trajectory from a wretched upper-class childhood, in which he's sexually abused by his father, through heroin addiction and, eventually, a hard-won redemption. The destructiveness of Melrose's parents, and his unlikely survival, trace British society's change in attitude, over the 20th century, from repression and oppression to liberalism. Savage, hilarious, glittering and tragic, these novels rank among the finest fiction of the past decades. In their fascination with torment, class and style, they're our closest contemporary equivalent to the work of Anthony Powell. There are, however, two St Aubyns. He can just as readily resemble Simon Raven, whose novels of upper-middle class life range from the slightly sparkling to the flat. Whether we get St Aubyn on Powellian or Ravenesque form, in my experience, depends on whether Patrick Melrose is involved. And in Parallel Lines, unfortunately, he is not. What one wants from a St Aubyn novel is, at the very least, a coke-snorting, Baudelaire-reading duke, who'll stub out a cigarette on a waiter before being sick in a gutter. But Parallel Lines is a sequel to 2021's Double Blind, which followed Lucy and Olivia, friends from the University of Oxford, as they navigated the world of high finance. The large cast of characters here, most of whom we've met before, ranges from high to low society, and none of them is badly behaved. Instead, St Aubyn's focus is on family. Olivia's husband is Francis, a worthy man who toils for an environmental charity, and they have a small son, Noah. Events revolve about the psychological problems of Sebastian, Olivia's twin brother, from whom she was separated at birth. She thrived in comfort; he was abused by their father and beset by psychosis. While their names immediately hint at Twelfth Night, there are no further Shakespearean resonances, bar the novel's general movement towards reunification. This, unfortunately, is typical. St Aubyn dips in and out of his characters' viewpoints somewhat randomly. A Catholic priest pops up, meditates, then vanishes. The plot is minimal, hinging on Olivia's adoptive father, who's also Sebastian's psychiatrist. He doesn't want them to meet for ethical reasons: hardly a powerful enough force to control a novel. The social chasm between Olivia and Sebastian is barely explored. The most convincing emotional thread concerns Olivia and Francis's tenderness towards Noah, but other characters are under-developed: Lucy suffers from a brain tumour, and her travails feel like an afterthought. It's clear, at least, that St Aubyn is fond of Sebastian. The latter's rehabilitation gives the novel its principal arc, and its best writing. When another patient stabs himself in the chest with a knife, believing that this action will open a portal to Japan, Sebastian muses: 'The doctors didn't understand what was going on at all and were treating him like some random loony who had stabbed himself in the chest.' Such mordant humour abounds. Still, nothing cuts too deeply, and you quickly begin to notice that everyone talks in this mannered way. One cameo character quips: 'Her pearls may have been cultured… but she most definitely was not.' That may sound clever, but isn't buying cultured pearls exactly what uncultured people do? The subject matter hums with wasted potential. Climate-change activists, high finance, modern art and cryogenics are on display. But wherever you expect St Aubyn to land a hit, he veers away. Francis has built an ark in his garden, in preparation for the day the waters rise. This would have engendered a withering putdown from a Melrose character; here, it doesn't cause an eyebrow to lift. Parallel Lines is underscored with gratitude for a happy family life, and for divisions healed – and that's all fair enough. Yes, contentment can forge good fiction. But how I longed for someone to puncture all the affectations, then pass out, cocktail in hand, on a nearby chaise longue. Let's hope St Aubyn gives Melrose another chance before too long.
